Skip to main content
Premium Trial:

Request an Annual Quote

CLC Bio Develops Informatics Plug-in for Symphogen

NEW YORK (GenomeWeb News) – CLC Bio has developed a software plug-in to work with Symphogen's antibody identification system, the Danish informatics company said today.

CLC developed a plug-in for its Main Workbench that is aimed at optimizing Symphogen’s Symplex technology for high-throughput antibody identification.

Jannick Bendsten, CLC Bio’s director of consulting services, said that the new plug-in is designed to analyze sequencing data coming from research projects conducted using the Symplex system, and to integrate that data into an end-to-end workflow.

Financial terms of the agreement were not released.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.